![Julie Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Smith
Directeur/Membre du Conseil chez
EXELIXIS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Julie Anne Smith is currently an Independent Director at Exelixis, Inc. since 2016 and an Independent Director at Stoke Therapeutics, Inc. since 2020.
Former roles include President, Chief Executive Officer & Director at Horizon Pharmaceutical LLC; President & Chief Executive Officer at Raptor Pharmaceuticals, Inc. from 2015 to 2016; President, Chief Executive Officer & Director at Nuredis, Inc. from 2017 to 2018; Chief Executive Officer & Director at Nuvig Therapeutics, Inc.; President, Chief Executive Officer & Director at ESCAPE Bio, Inc. from 2018 to 2022; Director-Channel Strategy & Design at Bristol Myers Squibb Co.; Director-Health & Emerging Companies Sections at Biotechnology Innovation Organization; Independent Director at Astellas Gene Therapies, Inc. from 2016 to 2020; Vice President-Commercial at Jazz Pharmaceuticals, Inc. from 2006 to 2008; Vice President-Global Marketing at Genzyme General from 2001 to 2005; Head-Operations & Business Development at Novazyme Pharmaceuticals, Inc. from 2000 to 2001; and Chief Commercial Officer & Vice President at Enobia Pharma, Inc. from 2008 to 2012.
Education includes undergraduate studies at Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EXELIXIS, INC. 0,01 % | 27/05/2026 | 28 957 ( 0,01 % ) | 1 M $ | 31/05/2026 |
| 03/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Julie Smith
| Sociétés | Poste | Début |
|---|---|---|
| EXELIXIS, INC. | Directeur/Membre du Conseil | 22/09/2016 |
| STOKE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/06/2020 |
Anciens postes connus de Julie Smith
| Sociétés | Poste | Fin |
|---|---|---|
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Directeur Général | 01/08/2022 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/01/2020 |
Nuredis, Inc.
 Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Directeur Général | 01/06/2018 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Directeur Général | 01/10/2016 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Corporate Officer/Principal | 01/05/2012 |
Formation de Julie Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Genzyme General
 Genzyme General Medical SpecialtiesHealth Technology Develops and markets specialty therapeutic, surgical, and diagnostic products | Health Technology |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops methods for modifying recombinantly produced enzymes | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Nuredis, Inc.
Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Health Technology |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
